| CAFFX | CGFAX | CAFFX / CGFAX | |
| Total Expense Ratio | 0.75 | 0.62 | 121% |
| Annual Report Gross Expense Ratio | 0.75 | 0.62 | 121% |
| Fund Existence | 24 years | 24 years | - |
| Gain YTD | -4.115 | 7.542 | -55% |
| Front Load | N/A | 4% | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 97.1B | 361B | 27% |
| Annual Yield % from dividends | 0.00 | 0.23 | - |
| Returns for 1 year | -1.30 | 4.35 | -30% |
| Returns for 3 years | 25.11 | 43.61 | 58% |
| Returns for 5 years | 3.62 | 15.48 | 23% |
| Returns for 10 years | 74.20 | 110.12 | 67% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VLACX | 138.73 | N/A | N/A |
| Vanguard Large Cap Index Investor | |||
| BDBPX | 31.82 | N/A | N/A |
| iShares Russell 2000 Small-Cap Idx Inv P | |||
| MDDAX | 9.43 | N/A | N/A |
| MassMutual Diversified Value A | |||
| GTMRX | 19.22 | N/A | N/A |
| Goldman Sachs Small/Mid Cap Growth R | |||
| MCYAX | 16.47 | -0.01 | -0.06% |
| NYLI Candriam Emerging Markets Eq Cl A | |||